![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
News
Vibalogics appoints global CEO to lead U.S. expansion
Vibalogics, a global contract development and manufacturing organization (CDMO) that specializes in the production of virotherapy products, has announced the appointment of Tom Hochuli...
News
Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine
Intravacc, a global provider of translational research and development of viral and bacterial vaccines, has been awarded a contract with base and options that...
Drug Research
PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line
PharmAbcine, a biotech company focusing on the development of antibody therapeutics, announced on August 31 that it had signed a contract manufacturing organization(CMO) agreement...
News
Cipla Health ventures into antifungal product category with launch of Clocip
Cipla Health Ltd., a leading consumer healthcare brand, has forayed into the antifungal product category with the introduction of Clocip, to offer a hardworking...
News
Roche announces FDA approval of Gavreto for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer
Roche announced that the United States (US) FDA has approved Gavreto™ (pralsetinib) for the treatment of adults with metastatic rearranged during transfection (RET) fusion-positive...
Clinical Trials
Merck announces positive results phase 3 trials of gefapixant 45 mg twice daily in patients with refractory or unexplained chronic cough
Merck, known as MSD outside the United States and Canada, has announced the results from two pivotal phase 3 trials (COUGH-1 and COUGH-2) evaluating...
News
Mylan to Acquire Aspen’s Thrombosis Business in Europe
Mylan N.V. announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read